Print this Page
News
Sandy Rollman Ovarian Cancer Foundation Donates $10,000 to Fox Chase Cancer Center
PHILADELPHIA (December 12, 2001) -- The Sandy Rollman Ovarian Cancer Foundation has donated $10,000 to Fox Chase Cancer Center for ovarian cancer research and prevention. The Foundation was initiated in the memory of Sandy Rollman, of Broomall, Pa., who died in 2000 at the age of 33 from ovarian cancer.
Rollman's sister Adriana D'Alessandro, of Broomall, Pa., (middle), and Rollman family friend and nurse Robin Cohen, of Drexel Hill, Pa., (right), presented the $10,000 check to Mary B. Daly, MD, PhD, director of the Margaret Dyson Family Risk Assessment Program.
The Family Risk Assessment Program is a prevention and early detection program specifically for women with a family history of breast and/or ovarian cancer. When the program opened in 1991, it was the first of its kind in the region and one of the first risk assessment programs in the nation. Today it is helping more than 3,286 women from 1,798 families.
In addition to their fundraising efforts for the Sandy Rollman Ovarian Cancer Foundation, D'Alessandro and Cohen actively support the Foundation's mission to promote awareness of ovarian cancer, advocate for increased research for early diagnostic testing and more effective treatments, and help advance research towards a cure.
In 2001, 23,400 women will be diagnosed with ovarian cancer while 13,900 will die of the disease. Ovarian cancer causes more deaths than any other cancer of the female reproductive system.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase also was among the first institutions to receive the National Cancer Institute’s prestigious comprehensive cancer center designation in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are routinely recognized in national rankings, and the Center’s nursing program has achieved Magnet status for excellence three consecutive times. Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research and oversees programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX-CHASE (1-888-369-2427).
